张振雷｜广西师范大学｜学者主页

期刊论文

2026

Developing a Molybdenum(IV) Agent Based on a Specific N-Donor Residue in Human Serum Albumin IB Subdomain: Multi-Targeted Inhibition of Growth and Metastasis in Hepatocellular Carcinoma

Gang Xu, Yiran Fu, Shanhe Li, Guochao Li, 秦继平, Zhenlei Zhang, Junzhu Li, Hong Liang, Feng Yang

Journal of Medicinal Chemistry

DOI

2025

Development of a theranostic tri-nuclear gadolinium(III) complex based on apoferritin for multitarget therapy of orthotopic glioma

Xueyu Man, Guochao Li, Minghui Zhu, Shanhe Li, Gang Xu, Zhenlei Zhang, Hong Liang, Feng Yang

Chinese Journal of Structural Chemistry

DOI

2025

Design of a theranostic Gd (III)–Cu (I) complex to inhibit growth and metastasis of triple‐negative breast cancer

Xueyu Man, Ming‐Hui Zhu, Shanhe Li, Wenjuan Li, Gang Xu, Zhenlei Zhang, Xiao‐Yang Wu, Hong Liang, Feng Yang

Rare Metals

DOI

2024

Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer

Gang Xu, Qiongyue Liang, Lijuan Gao, Shihang Xu, Weicong Luo, Qiuming Wu, Jingyuan Li, Zhenlei Zhang, Hong Liang, Feng Yang

Journal of Medicinal Chemistry

DOI

2024

Rational Design of a Hetero-multinuclear Gadolinium(III)–Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of Cancer

Xueyu Man, Wenjuan Li, Minghui Zhu, Shanhe Li, Gang Xu, Zhenlei Zhang, Hong Liang, Feng Yang

Journal of Medicinal Chemistry

DOI

2024

Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual‐Agent Combination Therapy for Cancer

Xueyu Man, Wenjuan Li, Minghui Zhu, Shanhe Li, Gang Xu, Zhenlei Zhang, Hong Liang, Feng Yang

Angewandte Chemie International Edition

DOI

2024

A novel Au(III) agent designed to inhibit tumor growth and metastasis through inducing immunogenic cell death

Wenjuan Li, Shanhe Li, Xueyu Man, Gang Xu, Zhenlei Zhang, Yao Zhang, Hong Liang, Feng Yang

Rare Metals

DOI

2024

Development of a Pt(II) compound based on indocyanine green@human serum albumin nanoparticles: integrating phototherapy, chemotherapy and immunotherapy to overcome tumor cisplatin resistance

Xueyu Man, Zewen Sun, Shanhe Li, Gang Xu, Wenjuan Li, Zhenlei Zhang, Hong Liang, Feng Yang

Rare Metals

DOI

2019

End-Group Functionalization of Polyethylene Glycol-Polylactic Acid Copolymer and Its Application in the Field of Pharmaceutical Carriers

Yanfang Chen, Jia-Yi Xu, Qinggang Tan, Zhenlei Zhang, Jun Zheng, Xiaoyan Xu, Yan Li

Journal of Biobased Materials and Bioenergy

DOI

2016

Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA Subdomain

Jinxu Qi, Yao Zhang, Yi Gou, Zhenlei Zhang, Zuping Zhou, Xiaoyang Wu, Feng Yang, Hong Liang

Molecular Pharmaceutics

DOI

2015

Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism

Jinxu Qi, Shichu Liang, Yi Gou, Zhenlei Zhang, Zuping Zhou, Feng Yang, Hong Liang

European Journal of Medicinal Chemistry

DOI

2014

Novel 3‐Substituted Ocotillol‐Type Triterpenoid Derivatives as Antibacterial Candidates

Y. Bi, Cong Ma, Heng-Yuan Zhang, Zhi-Wen Zhou, Jian Yang, Zhenlei Zhang, Qing-Guo Meng, P. Lewis, Jin-Yi Xu

Chemical Biology and Drug Design

DOI

会议论文

2019

基于功能蛋白质发展抗胶质瘤金属药物（英文）

Zhenlei Zhang, Hong Liang, 杨峰

《第十一届全国化学生物学学术会议论文摘要（第一卷）》

DOI

2017

Nucleolar-Targeting Platinum-based Agent Expresses Increased Toxicity and Overcomes Platinum Drug Resistance in Cancer Cells

Zhenlei Zhang, Xin Qiao, Jingyuan Xu

《第十届全国化学生物学学术会议论文摘要集（墙报）》

张振雷

精选作品

期刊论文

Developing a Molybdenum(IV) Agent Based on a Specific N-Donor Residue in Human Serum Albumin IB Subdomain: Multi-Targeted Inhibition of Growth and Metastasis in Hepatocellular Carcinoma

Development of a theranostic tri-nuclear gadolinium(III) complex based on apoferritin for multitarget therapy of orthotopic glioma

Design of a theranostic Gd (III)–Cu (I) complex to inhibit growth and metastasis of triple‐negative breast cancer

Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer

Rational Design of a Hetero-multinuclear Gadolinium(III)–Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of Cancer

Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual‐Agent Combination Therapy for Cancer

A novel Au(III) agent designed to inhibit tumor growth and metastasis through inducing immunogenic cell death

Development of a Pt(II) compound based on indocyanine green@human serum albumin nanoparticles: integrating phototherapy, chemotherapy and immunotherapy to overcome tumor cisplatin resistance

End-Group Functionalization of Polyethylene Glycol-Polylactic Acid Copolymer and Its Application in the Field of Pharmaceutical Carriers

Developing an Anticancer Copper(II) Pro-Drug Based on the His242 Residue of the Human Serum Albumin Carrier IIA Subdomain

Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism

Novel 3‐Substituted Ocotillol‐Type Triterpenoid Derivatives as Antibacterial Candidates

会议论文

基于功能蛋白质发展抗胶质瘤金属药物（英文）

Nucleolar-Targeting Platinum-based Agent Expresses Increased Toxicity and Overcomes Platinum Drug Resistance in Cancer Cells

研究方向